Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Evaluating the Role of Endogenous Opioids in Pain Relief from Spine Injections

Official title: Antagonism of Endogenous Opioids: Use in Interpretation of Injections

Run by Middle Tennessee Research Institute · NCT06666621 · Data updated 2026-11-12

This study is testing how well lumbar spine injections relieve pain in people with low back pain and arthritis, while also seeing if the body's natural painkillers play a role in that relief.

More Low Back Pain trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment33 (estimated)
SponsorMiddle Tennessee Research Institute
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedAugust 22, 2024
Main results expectedOctober 2025
Study endsFebruary 2026
Registry record updatedMay 18, 2025
Trial IDNCT06666621 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults experiencing low back pain for at least three months with significant symptoms despite conventional treatments.

Probably not a fit

Patients currently using opioid medications or those with certain spinal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the pain relief effects of lumbar medial branch blocks (LMBB) in patients with low back pain and zygapophyseal joint arthritis. It aims to differentiate between the physiological effects of the nerve block and the placebo response by using naloxone, an opioid receptor antagonist, to block the body's endogenous opioids. By measuring pain relief before and after the administration of naloxone, the study seeks to enhance understanding of how these injections guide pain management. The findings could lead to improved treatment protocols for patients suffering from chronic low back pain.

Why it matters

Potential benefit: If successful, this study could lead to more accurate pain management strategies for patients with low back pain.

How similar studies have gone: While the use of naloxone to assess placebo responses is innovative, similar studies have shown promise in understanding pain management, though this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Capable of understanding and providing consent in English and capable of complying with the outcome instruments used
* ≥3 months low back pain with persistent limiting symptoms despite conventional treatment (physical therapy and oral medications)
* Low back pain NRS ≥ 4/10 in intensity on 7-day average and at time of lumbar medial branch block

Exclusion Criteria:

* Daily use of opioid medications or recreational drugs, or if using opioids PRN, report of opioid use within the 3 days prior to participating in the protocol
* Positive urine drug screen for opioid medication on the day of naloxone administration
* Allergy to naloxone
* Refusal of or failure to place IV
* Previous LMBB or LMBRN
* Known spine condition that may affect the ability to diagnose or treat facet pain or lead to spine surgery (e.g. instability, severe spinal stenosis, radiculopathy, previous spine operation resulting in alteration of anatomy targeted by LMBB or LMBRFN)
* Active medical condition that would limit the safety of naloxone administration (e.g. severe kidney or liver failure, unstable cardiac disease, infection, severe coagulopathy)
* Psychiatric, medical, neurologic, or pain-related disorder that may compromise the ability of the patient to accurately report changes in low back pain
* Requirement for procedural sedation to tolerate LMBB

Where it's running

  • VA Tennessee Valley Healthcare System
    Nashville, Tennessee, United States
    Recruiting

Study contacts

  • Principal investigator: William E Rivers, DO — Tennessee Valley Healthcare System VA
  • Study coordinator: William E Rivers, DO
  • Email: william.rivers@va.gov
  • Phone: 859-513-9793

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.